Prostate Cancer
How do you teach the immune system to hate prostate cancer?
February 9, 2013
The impact of socioeconomic status on prostate cancer treatment and survival in the Southern Netherlands - Abstract
February 9, 2013
Evaluation of novel formula of PSA, age, prostate volume, and race in predicting positive prostate biopsy findings - Abstract
February 9, 2013
Abiraterone in metastatic prostate cancer without previous chemotherapy (from study COU-AA-302)
February 9, 2013
The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis - Abstract
February 9, 2013
Image-guided hypofractionated radiotherapy and quality of life in localized prostate cancer: Prospective longitudinal study on 337 patients - Abstract
February 9, 2013
Is an extended 20-core prostate biopsy protocol more efficient than the the standard 12-core? A randomized multicenter trial - Abstract
February 9, 2013
Epoch making development of new drugs for prostate cancer - Abstract
February 8, 2013
Abiraterone and increased survival in metastatic prostate cancer (from study COU-AA-301)
February 8, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer - Abstract
February 7, 2013
The building and validation of a model to predict the bone metastases of patients with newly diagnosed prostate cancer - Abstract
February 7, 2013
Radical prostatectomy in high-risk prostate cancer - Abstract
February 7, 2013
Tumour-to-tumour metastases: Prostate carcinoma metastasising to a renal oncocytoma - Abstract
February 7, 2013
Susceptibility weighted imaging: A new tool in the diagnosis of prostate cancer and detection of prostatic calcification - Abstract
February 7, 2013